Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts

Published:2010-07 Issue:4 Volume:2 Page:449-456
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Li Jing,Zhou Bo,Shentu Jianzhong,Du Li,Tan Min,Hou Sheng,Qian Weizhu,Li Bohua,Zhang Dapeng,Dai Jianxin,Wang Hao,Zhang Xu,Chen Jianghua,Guo Yajun

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/mabs.12305

Reference32 articles.

1. A Prospective Study on the Use of Monoclonal Anti—T3-Cell Antibody (OKT3) to Treat Steroid-Resistant Liver Transplant Rejection

2. TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL ANTIBODY

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune rebalancing by oral immunotherapy: A novel method for getting the immune system back on track;Journal of Leukocyte Biology;2018-11-26

2. Characterization of a surrogate murine antibody to model anti-human CD3 therapies;mAbs;2013-07

3. Applications of minimal physiologically-based pharmacokinetic models;Journal of Pharmacokinetics and Pharmacodynamics;2012-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP